The global neuroendocrine carcinoma market, valued at USD 1.56 billion in 2021, is projected to experience significant growth over the next decade. According to Straits Research, the market is anticipated to expand at a compound annual growth rate (CAGR) of 7.96% from 2022 to 2030, reaching a valuation of USD 3.11 billion by the end of the forecast period. https://www.blogger.com/blog/post/edit/9199106166096138421/665927569293993435